Activity

A new fluorescence probe L, which featured with a large Stokes shift (216 nm), was designed for sensitive detection of cysteine (Cys) and a potential sensing mechanism derived from excited state intramolecular proton transfer (ESIPT) was proposed. More importantly, probe L exhibits higher selective to Cys than other amino acid due to its specific cyclization between acrylate group and Cys. Meanwhile, the probe L shows a low detection limit of 8.82 × 10-8 M, which is enough for detecting Cys in organisms. Furthermore, this probe displays high biocompatibility and can image Cys in living cells.Contamination of agricultural plants and food in the environment caused by pesticide residues has gained great attention of the world. Pesticide residues on vegetables constitute a potential risk to human health. A visible/near-infrared (Vis/NIR) spectroscopy combined with chemometric methods was employed to quantitatively determine chlorpyrifos and carbendazim residues in the cabbage (Brassica chinensis L.). Preprocessing methods were used for spectra denoising. Partial least squares regression (PLSR) and least squares-support vector machine (LS-SVM) were applied as the quantification models. Feature variables were selected by successive projection algorithms (SPA), random frog and regression coefficients in PLSR. As for the samples with chlorpyrifos residues, LS-SVM models based on the global spectra achieved best model performance. The best performance for carbendazim content prediction was achieved by the LS-SVM models based on the original global spectra. And modeling with SPA selected feature variables for carbendazim determination was as good as modeling with the global spectra. The results indicated that Vis/NIR spectroscopy coupled with chemometrics could be an efficient way for the assessment of the pesticide residues in vegetables, and was significant for detection of environmental pollution and ensuring food safety.Herein we designed a novel, highly sensitive, simple and amplified fluorescence immunosensing strategy for hepatitis B virus surface antigen (HBV surface antigen) (HBsAg) as a model based on the construction of a sandwich type probe. The operation mechanism of this immunosensing strategy is implemented by capturing and then stimulation-based-releasing of entrapped dye in the fluorescent capsules. Nevirapine mouse The proposed probe is made by the Fe3O4 magnetic nanoparticle (Fe3O4 MNP) as a probe collector site and the Rhodamine B loaded-mesoporous silica nanoparticle (MSN-Rh.B) as a fluorescent mesoporous capsule and signal amplifier site. Such a methodology is benefited, from the advantages of the high ability of MSNs to be used as a scaffold for efficient dye encapsulation and the magnetic nanoparticles as efficient biological carriers. Under optimal conditions, the fluorescence signal (The fluorescence of solutions was measured using a quartz fluorescence cell (PMT voltage720, Ex wavelegth540, Em wavelength568, All measurements were carried out at room temperature) increased with the increment of HBsAg concentration in the linear dynamic range of 6.1 ag/ml to 0.012 ng/ml with a detection limit (LOD) of 5.7 ag/ml. The relative standard deviation, measured between the resulting fluorescence peaks was obtained by 6.0%.The extracellular matrix (ECM) is an important biophysical environment that plays a role in a number of physiological processes. The ECM is highly dynamic, with changes occurring as local, nanoscale, physicochemical variations in physical confinement and chemistry from the perspective of biological molecules. The length and time scale of ECM dynamics are challenging to measure with current spectroscopic techniques. Super-resolution fluorescence microscopy has the potential to probe local, nanoscale, physicochemical variations in the ECM. Here, we review super-resolution imaging and analysis methods and their application to study model nanoparticles and biomolecules within synthetic ECM hydrogels and the brain extracellular space (ECS). We provide a perspective of future directions for the field that can move super-resolution imaging of the ECM towards more biomedically-relevant samples. Overall, super-resolution imaging is a powerful tool that can increase our understanding of extracellular environments at new spatiotemporal scales to reveal ECM processes at the molecular-level.Liver X receptor β (LXRβ), a nuclear receptor involved in important cellular processes such as cholesterol, glucose and fatty acid metabolism, was suggested to be involved in platelet aggregation but its detailed roles are not clear. In the present study, we evaluated the contribution of LXRβ to platelet functions and production. In the systemic collagen-epinephrine thrombosis mouse model, LXRβ-deficient mice showed increased area of blood clots compared with control wide-type littermates. The aggregation of LXRβ-deficient platelets in response to ADP was stronger than that of control mice platelets. More importantly, the number of platelets in blood of LXRβ-deficient mice was significantly higher than that of wild-type mice, especially for female mice. Knockdown of LXRβ expression in human megakaryoblastic Dami cells also enhanced cell polyploidization, formation of proplatelets and production of platelet-like particles. Increase in expression levels of proteins related to oxidative phosphorylation such as NADHubiquinone oxidoreductase core subunit V1 (Ndufv1) was observed in LXRβ-knockdown Dami cells. The levels of Ndufv1 in LXRβ-deficient mice platelets were also higher than that of wild-type mice. Taken together, our findings suggested LXRβ might participate in control of platelet production from megakaryocytes by regulating mitochondrial metabolism.Patients with a primary diagnosis of sickle cell disease (SCD) with or without crisis during the 10-year period January 2009 to December 2018 were identified in the HES Admitted Patient Care (APC) dataset and matched with the Office for National Statistics (ONS) mortality dataset. Three sub-cohorts were defined ‘crises’, ‘transfusions’ and ‘other SCD’. APC records were examined for co-morbidities commonly associated with SCD and 10-year mortality rates compared with the general population. After data cleaning and exclusions, 9503 patients remained (entire cohort), with 1171, 201, and 8131 in crises, transfusions, and other SCD sub-cohorts, respectively. Median numbers of co-morbidities per patient were 2 (Interquartile range (IQR) 1-4), 2 (IQR 1-3), and 1 (IQR 0-2) in the crises, transfusions, and other SCD sub-cohorts, respectively. The majority of patients in the crises (63.2%) and transfusions (56.3%) cohorts had ≥2 co-morbidities, compared with 25.3% in the other SCD sub-cohort. Crude 10-year mortality rate was 5.